NO20025883L - Thiazolidinone salt for the treatment of diabetes mellitus - Google Patents

Thiazolidinone salt for the treatment of diabetes mellitus

Info

Publication number
NO20025883L
NO20025883L NO20025883A NO20025883A NO20025883L NO 20025883 L NO20025883 L NO 20025883L NO 20025883 A NO20025883 A NO 20025883A NO 20025883 A NO20025883 A NO 20025883A NO 20025883 L NO20025883 L NO 20025883L
Authority
NO
Norway
Prior art keywords
thiazolidinone
salt
treatment
diabetes mellitus
mellitus
Prior art date
Application number
NO20025883A
Other languages
Norwegian (no)
Other versions
NO20025883D0 (en
Inventor
Andrew Simon Craig
Tim Chien Ting Ho
Original Assignee
Smithkline Beecham Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Plc filed Critical Smithkline Beecham Plc
Publication of NO20025883D0 publication Critical patent/NO20025883D0/en
Publication of NO20025883L publication Critical patent/NO20025883L/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/12Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Diabetes (AREA)
  • General Chemical & Material Sciences (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
NO20025883A 2000-06-08 2002-12-06 Thiazolidinone salt for the treatment of diabetes mellitus NO20025883L (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0014006.1A GB0014006D0 (en) 2000-06-08 2000-06-08 Novel pharmaceutical
PCT/GB2001/002567 WO2001094344A1 (en) 2000-06-08 2001-06-08 Thiazolidinedione salt for treatment of diabetes mellitus

Publications (2)

Publication Number Publication Date
NO20025883D0 NO20025883D0 (en) 2002-12-06
NO20025883L true NO20025883L (en) 2003-02-03

Family

ID=9893257

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20025883A NO20025883L (en) 2000-06-08 2002-12-06 Thiazolidinone salt for the treatment of diabetes mellitus

Country Status (23)

Country Link
EP (1) EP1296980A1 (en)
JP (1) JP2003535862A (en)
KR (1) KR20030007918A (en)
CN (1) CN1443186A (en)
AP (1) AP2002002673A0 (en)
AU (1) AU2001264078A1 (en)
BG (1) BG107357A (en)
BR (1) BR0111536A (en)
CA (1) CA2411065A1 (en)
CZ (1) CZ20023966A3 (en)
DZ (1) DZ3382A1 (en)
EA (1) EA200300005A1 (en)
GB (1) GB0014006D0 (en)
HU (1) HUP0301137A3 (en)
IL (1) IL153279A0 (en)
MA (1) MA25753A1 (en)
MX (1) MXPA02012100A (en)
NO (1) NO20025883L (en)
OA (1) OA12284A (en)
PL (1) PL360592A1 (en)
SK (1) SK17142002A3 (en)
WO (1) WO2001094344A1 (en)
ZA (1) ZA200209954B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
USRE39384E1 (en) 1993-09-01 2006-11-07 Smithkline Beecham P.L.C. Substituted thiazolidinedione derivatives
DE102005034406A1 (en) * 2005-07-22 2007-02-01 Ratiopharm Gmbh New salts of rosiglitazone
US20080176905A1 (en) * 2007-01-22 2008-07-24 Santiago Ini Polymorphic forms of rosiglitazone hydrobromide and processes for preparation thereof
EP1956018A1 (en) * 2007-02-06 2008-08-13 Boehringer Ingelheim Pharma GmbH & Co. KG Method of preparing a derivative of benzimidazole
US20100056583A1 (en) * 2008-08-21 2010-03-04 Teva Pharmaceutical Industries Ltd. Polymorphic forms of rosiglitazone hydrobromide and processes for their preparation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9218830D0 (en) * 1992-09-05 1992-10-21 Smithkline Beecham Plc Novel compounds

Also Published As

Publication number Publication date
OA12284A (en) 2003-11-10
KR20030007918A (en) 2003-01-23
PL360592A1 (en) 2004-09-20
JP2003535862A (en) 2003-12-02
EA200300005A1 (en) 2003-04-24
CN1443186A (en) 2003-09-17
BG107357A (en) 2003-08-29
MXPA02012100A (en) 2003-04-25
HUP0301137A2 (en) 2003-08-28
EP1296980A1 (en) 2003-04-02
MA25753A1 (en) 2003-04-01
NO20025883D0 (en) 2002-12-06
IL153279A0 (en) 2003-07-06
AP2002002673A0 (en) 2002-12-31
CA2411065A1 (en) 2001-12-13
AU2001264078A1 (en) 2001-12-17
WO2001094344A1 (en) 2001-12-13
BR0111536A (en) 2003-07-01
HUP0301137A3 (en) 2005-04-28
GB0014006D0 (en) 2000-08-02
DZ3382A1 (en) 2001-12-13
SK17142002A3 (en) 2003-10-07
CZ20023966A3 (en) 2003-04-16
ZA200209954B (en) 2003-10-10

Similar Documents

Publication Publication Date Title
NO20020764D0 (en) Benzoic acid derivatives for the treatment of diabetes mellitus
ATE344253T1 (en) THIAZOLE DERIVATIVES FOR THE TREATMENT OF PPAR-LATED DISEASES
NO20033203L (en) Therapeutic heterocyclic compounds
NO20022087D0 (en) Procedure for the treatment of diabetes
NO20006630L (en) Pharmaceutical composition for the treatment of diabetes
IL160884A0 (en) Azabicyclic-substituted fused-heteroaryl compounds for the treatment of disease
HK1087103A1 (en) Anilinopyrazole derivatives useful for the treatment of diabetes
NO20021474L (en) Compounds for the treatment of ischemia
NO20013380D0 (en) 2-aminobenzoxazinone derivatives for the treatment of obesity
PL370818A1 (en) Dosage form for treatment of diabetes mellitus
NO20052894D0 (en) 4-tetrazolyl-4-phenylpiperidine derivatives for the treatment of pain
IS6918A (en) Treatment of difficult tumors with the use of epothilone derivatives
IS6917A (en) Epothilone derivatives for the treatment of difficult tumors
NO20013381D0 (en) 2-oxybenzoxazinone derivatives for the treatment of obesity
NO20024775D0 (en) Hydroxyphenyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
AU2003279442A8 (en) 2-thiohydantoine derivative compounds and use thereof for the treatment of diabetes
NO20045554L (en) Procedure for the treatment of diabetes
NO20015288D0 (en) Use of macrolide compounds for the treatment of dry eye
DE60203537D1 (en) 5HT1-RECEPTORAGONIST-CONTAINING MEDICAMENT
NO20033804D0 (en) Carbamate compounds for the treatment of pain
NO20024777L (en) Quinolinyl-piperidin-4-ylidene-methyl-benzamide derivatives for the treatment of pain
NO20024776D0 (en) Hydroxyphenyl-piperazinyl-methyl-benzamide derivatives for the treatment of pain
NO20025883L (en) Thiazolidinone salt for the treatment of diabetes mellitus
NO20043483L (en) Use of melagatran for the manufacture of a drug for the treatment of type 1 diabetes mellitus
NO20012612L (en) Isonipecotamides for the treatment of integrin-mediated diseases

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application